Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value $0.01 per share
-
Shares outstanding
-
17.3M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
5.17M
-
Shares change
-
-3.06M
-
Total reported value, excl. options
-
$10.7M
-
Value change
-
-$7.98M
-
Put/Call ratio
-
0.11
-
Number of buys
-
26
-
Number of sells
-
-32
-
Price
-
$2.07
Significant Holders of Mural Oncology plc - Ordinary Shares, nominal value $0.01 per share (MURA) as of Q3 2025
80 filings reported holding MURA - Mural Oncology plc - Ordinary Shares, nominal value $0.01 per share as of Q3 2025.
Mural Oncology plc - Ordinary Shares, nominal value $0.01 per share (MURA) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.17M shares
of 17.3M outstanding shares and own 29.98% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (589K shares), Newtyn Management, LLC (523K shares), OMERS ADMINISTRATION Corp (511K shares), VANGUARD GROUP INC (455K shares), Rangeley Capital, LLC (305K shares), BlackRock, Inc. (288K shares), RBF Capital, LLC (284K shares), MILLENNIUM MANAGEMENT LLC (258K shares), CITADEL ADVISORS LLC (258K shares), and DELTEC ASSET MANAGEMENT LLC (179K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.